| Racial disparity in oxygen saturation measurements by pulse oximetry: evidence and implications H Jamali, LT Castillo, CC Morgan, J Coult, JL Muhammad, OO Osobamiro, ... Annals of the American Thoracic Society 19 (12), 1951-1964, 2022 | 54 | 2022 |
| Identification of multiple structurally distinct, nonpeptidic small molecule inhibitors of protein arginine deiminase 3 using a substrate-based fragment method H Jamali, HA Khan, JR Stringer, S Chowdhury, JA Ellman Journal of the American Chemical Society 137 (10), 3616-3621, 2015 | 38 | 2015 |
| Cellular activity of new small molecule protein arginine deiminase 3 (PAD3) inhibitors H Jamali, HA Khan, CC Tjin, JA Ellman ACS Medicinal Chemistry Letters 7 (9), 847-851, 2016 | 25 | 2016 |
| Synthesis and biological evaluation of an indazole-based selective protein arginine deiminase 4 (PAD4) inhibitor CC Tjin, RF Wissner, H Jamali, A Schepartz, JA Ellman ACS Medicinal Chemistry Letters 9 (10), 1013-1018, 2018 | 19 | 2018 |
| Synthesis and evaluation of macrocyclic peptide aldehydes as potent and selective inhibitors of the 20S proteasome DL Wilson, I Meininger, Z Strater, S Steiner, F Tomlin, J Wu, H Jamali, ... ACS medicinal chemistry letters 7 (3), 250-255, 2016 | 17 | 2016 |
| An allosteric site on MKP5 reveals a strategy for small-molecule inhibition ZTK Gannam, K Min, SR Shillingford, L Zhang, J Herrington, L Abriola, ... Science signaling 13 (646), eaba3043, 2020 | 16 | 2020 |
| Defining the structure-activity relationship for a novel class of allosteric MKP5 inhibitors ZTK Gannam, H Jamali, OS Kweon, J Herrington, SR Shillingford, ... European journal of medicinal chemistry 243, 114712, 2022 | 4 | 2022 |
| Ibrutinib response in a patient with refractory mixed essential cryoglobulinemia H Jamali, D Wu, L Soma, M Linenberger, MH Wener, L Silberstein EJHaem 4 (2), 499, 2023 | 2 | 2023 |
| Compounds and Compositions for Treating Fibrosis A Bennett, J Ellman, H Jamali, KS Anderson, E Lolis, D Hoyer US Patent App. 18/589,173, 2024 | | 2024 |
| Next generation triplex-forming PNAs for site-specific genome editing of the F508del CFTR mutation A Gupta, C Barone, E Quijano, AS Piotrowski-Daspit, JD Perera, ... Journal of Cystic Fibrosis, 2024 | | 2024 |
| What’s the Difference Anyway? H Jamali, AM Luks Annals of the American Thoracic Society 21 (4), 663-668, 2024 | | 2024 |
| Compounds and Compositions for Treating Fibrosis A Bennett, J Ellman, H Jamali, KS Anderson, E Lolis, D Hoyer US Patent App. 18/047,456, 2023 | | 2023 |
| Don’t Be So Dense! H Jamali, AM Luks Annals of the American Thoracic Society 20 (4), 605-608, 2023 | | 2023 |
| Compounds and compositions for treating fibrosis A Bennett, J Ellman, H Jamali, KS Anderson, E Lolis, D Hoyer US Patent 11,504,373, 2022 | | 2022 |
| A man with chronic asymptomatic hypoxemia H Jamali, AK Brady, R Adamson Annals of the American Thoracic Society 18 (10), 1728-1732, 2021 | | 2021 |
| EXPANSION OF THE NASAL AND TRACHEAL EPITHELIAL CELLS FROM A SINGLE MOUSE GENERATES MULTIPLE ALI MONOLAYERS C Barone, H Jamali, A Piotrowski-Daspit, R Nguyen, PM Glazer, ... PEDIATRIC PULMONOLOGY 54, S315-S316, 2019 | | 2019 |
| GENE EDITING OF CLASS I CFTR MUTATIONS MEDIATED BY PNA NANOPARTICLES A Piotrowski-Daspit, C Barone, C Lin, H Jamali, R Nguyen, A Riccardi, ... PEDIATRIC PULMONOLOGY 54, S213-S213, 2019 | | 2019 |
| REAL-TIME MEASUREMENT OF CELL RESISTANCE REVEALS DEFECTIVE PERMEABILITY IN CF BRONCHIAL EPITHELIAL CELLS C Sendon, HH Oz, C Di Pietro, C Barone, H Jamali, R Pierce, ME Egan, ... PEDIATRIC PULMONOLOGY 53, 184-184, 2018 | | 2018 |
| CORRECTION OF CFTR MUTATIONS USING PEPTIDE NUCLEIC ACIDS DELIVERED IN POLYMERIC NANOPARTICLES IN VITRO H Jamali, A Gupta, C Barone, A Riccardi, E Quijano, A Piotrowski-Daspit, ... PEDIATRIC PULMONOLOGY 53, 151-151, 2018 | | 2018 |
| Synthesis of bimodal inhibitors of the 20S proteasome H Jamali | | 2012 |
